Nagoya, Japan

Hiroyasu Andoh

This inventor holds 1 USPTO granted patent. Top assignee: Amano Enzyme Inc.. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroyasu Andoh: Innovator in Enzyme Technology

Introduction

Hiroyasu Andoh is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of enzyme technology, particularly in the development of oral dosage forms for mammals. His innovative approach has the potential to impact dietary health and fat management in mammals.

Latest Patents

Hiroyasu Andoh holds a patent for an enzyme in a dosage form for oral use in mammals. This enzyme is designed to convert fat in food materials into 1,3-diglyceride and/or 1-monoglyceride. The patent describes a method for administering this enzyme, which has not been conventionally used for oral dosing in mammals. The enzyme in this oral dosage form can effectively decrease body fat and internal fat in mammals during general dietary life. He has 1 patent to his name.

Career Highlights

Hiroyasu Andoh is associated with Amano Enzyme Inc., a company that specializes in enzyme production and application. His work at the company has allowed him to explore innovative solutions in enzyme technology, contributing to advancements in health and nutrition.

Collaborations

Hiroyasu Andoh collaborates with Yuzo Kojima, a fellow innovator in the field. Their partnership enhances the research and development efforts at Amano Enzyme Inc., fostering a collaborative environment for innovation.

Conclusion

Hiroyasu Andoh's contributions to enzyme technology represent a significant advancement in dietary health solutions. His innovative patent and collaboration with industry professionals highlight the importance of research in improving health outcomes for mammals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…